| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 1364959 | Bioorganic & Medicinal Chemistry Letters | 2008 | 4 Pages | 
Abstract
												A versatile synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxylate esters has been developed which has lead to the identification of a new series of non-nucleoside inhibitors of human herpesvirus polymerases HCMV, HSV-1, EBV, and VZV with high specificity compared to human DNA polymerases.
Graphical abstractA new series of broad-spectrum herpesvirus polymerase inhibitors has been identified with antiviral activity against HCMV, HSV-1, EBV, and VZV. A practical synthesis of furo[2,3-b]pyridin-4-one-5-carboxylate esters is described.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
												
													Physical Sciences and Engineering
													Chemistry
													Organic Chemistry
												
											Authors
												Mark E. Schnute, Roger J. Brideau, Sarah A. Collier, Michele M. Cudahy, Todd A. Hopkins, Mary L. Knechtel, Nancee L. Oien, Robert S. Sackett, Allen Scott, Mari L. Stephan, Michael W. Wathen, Janet L. Wieber, 
											![First Page Preview: Synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibition Synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibition](/preview/png/1364959.png)